Case report: ex vivo tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinoma.
Al-Aloosi M, Prechtl AM, Chatterjee P, Bernard B, Kemp CJ, Rosati R, Diaz RL, Appleyard LR, Pereira S, Rajewski A, McDonald A, Gordon EJ, Grandori C.
Al-Aloosi M, et al. Among authors: bernard b.
Front Oncol. 2024 Jan 4;13:1267650. doi: 10.3389/fonc.2023.1267650. eCollection 2023.
Front Oncol. 2024.
PMID: 38239650
Free PMC article.